Overview:
Genome engineering is a collection of biomedical techniques that can be used to modify DNA bases in an organism. It has been used for decades to modify genomes of many organisms and some mammals. Gene therapy is divided in two types, Ex-Vivo Gene Therapy and In-Vivo Gene Therapy. In Ex-Vivo gene Therapy, genes are transferred into cultured cells and then reintroduced in the patient. Whereas, in In-Vivo Gene Therapy involves direct introduction of genes to cells of a specific tissue. There are many advanced tools for gene engineering that allows modification of genomes by adding and altering sections of DNA sequence. CRISPR, one of the techniques used for DNA editing, it is faster, accurate, and economic in comparison with other techniques.
Get Your FREE Sample Copy of the Genome Engineering Market Report 2021
Drivers:
Introduction of novel technologies in genome engineering by market players is expected to augment the global genome engineering market growth over the forecast period. For instance, in February 2018, Sangamo announced the U.K. Authorization of clinical trial evaluating zinc finger nuclease in vivo genome editing treatment for hemophilia B. Moreover, in July 2017, Integrated DNA Technologies (IDT) announced the launch of the first Cas9 enzyme variant that extensively reduces off-target effects in CRISPR genome editing without compromising on-target activity. Furthermore, in December 2017, Salk scientists created a new version of the CRISPR/Cas9 genome editing technology that allows them to activate genes without creating breaks in the DNA, potentially circumventing a major hurdle to using gene editing technologies to treat human diseases.
Moreover, market players are adopting various inorganic strategies, such as collaboration and partnership, to strengthen their product portfolio, as well as to strengthen their market position. This in turn is expected to drive the global genome engineering market growth. For instance, in February 2018, Kite Pharma and Sangamo Therapeutics collaborated to develop engineered cell therapies to treat cancer. Similarly, in 2017, Synthego collaborated with Thermo Fisher to manufacture and distribute synthetic guide RNA products for CRISPR genome engineering.
Ask for PDF sample copy of the Genome Engineering market report @ https://www.coherentmarketinsights.com/insight/request-pdf/1262
Furthermore, increase in research development for novel technologies is also expected to boost the growth of the global genome engineering market. For instance, in 2018, the U.S. National Institutes of Health (NIH) invested around US$ 190 million for genome editing research.
Restraints:
High cost associated with the development of novel genome engineering technologies is expected to hamper the growth of the global genome engineering market during the forecast period. Moreover, genome engineering is a very complex technology and needs high skilled researchers, which in turn is also expected to hinder the market growth.
Market Taxonomy:
By Technology;
- CRISPR
- TALEN
- ZFN
By Application:
- Cell Line Engineering
- Genetic Engineering
By End User:
- Biotechnology & Pharmaceutical Companies
- Research Institutes
- Contract Research Organizations
By Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
Buy Now this Premium Report to Grow your Business: https://www.coherentmarketinsights.com/insight/buy-now/1262
Reasons to Purchase this Report
• Current and future of global Genome Engineering market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
“Limited Time Offer”
Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.
We also offer 15% FREE Report customization.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/1262
Key players:
Key players operating in the genome engineering market are Merck Group, Cellectis S.A., Bluebird Bio, Inc., Sangamo Therapeutics, Inc., Editas Medicine, Inc., Intellia Therapeutics, Inc., CRISPR Therapeutics AG, and Thermo Fisher Scientific Inc.
Table of Content
Global Genome Engineering Market Research Report
Section 1: Global Genome Engineering Industry Overview
Section 2: Global Economic Impact on Genome Engineering Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Genome Engineering Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Genome Engineering Market Forecast
Other Exclusive Reports:
Regenerative Medicine (Bone and Joint) Market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837